ATS: Benralizumab Reduces Glucocorticoid Doses in Asthma

Benralizumab is associated with a significant reduction in glucocorticoid doses among adults with severe asthma, according to a study published online May 22 in the New England Journal of Medicine.

» Read more

Source: HealthDay